Groundbreaking Stem Cell Study Restores Walking Ability in Paralyzed Patient
The results from Mayo Clinic’s groundbreaking Phase I clinical trial are in. The utilized intrathecal delivery of adipose-derived (fat-derived) stem cells to treat traumatic spinal cord injuries, leading to remarkable improvements in motor function and sensation, including restoring function to a previously paralyzed patient.
April 15, 2024